Nirsevimab: The Hidden Costs
Author:
Affiliation:
1. Nemours Children’s Health, Wilmington, Delaware; and Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania
Publisher
American Academy of Pediatrics (AAP)
Link
https://publications.aap.org/hospitalpediatrics/article-pdf/14/6/e276/1658931/hpeds.2024-007739.pdf
Reference18 articles.
1. Use of nirsevimab for the prevention of respiratory syncytial virus disease among infants and young children: recommendations of the Advisory Committee on Immunization Practices—United States, 2023;Jones;MMWR Morb Mortal Wkly Rep,2023
2. Safety of nirsevimab for RSV in infants with heart or lung disease or prematurity;Domachowske;N Engl J Med,2022
3. Nirsevimab for prevention of RSV in term and late-preterm infants;Muller;N Engl J Med,2023
4. Single-dose nirsevimab for prevention of RSV in preterm infants;Griffin;N Engl J Med,2020
5. Cost-effectiveness of respiratory syncytial virus prophylaxis in various indications;Hampp;Arch Pediatr Adolesc Med,2011
Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Independent Analysis of the Results of the First Infant Immunization Campaign with Beyfortus® (Nirsevimab, Monoclonal Antibody Against RSV Bronchiolitis Virus): Mixed Results, Identification of Biases, and Possible Role and Mechanisms of ADE (Antibody Dependent Enhancement);2024-06-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3